on AMOEBA (EPA:ALMIB)
Amoéba Schedules Ordinary and Extraordinary General Meeting
Amoéba, a French industrial greentech company, announced its Ordinary and Extraordinary General Meeting is set for April 3, 2026. The meeting will be held at the company's registered office in Chassieu, France, at 9:00 am. Shareholders will have access to the meeting notice, agenda, and draft resolutions, which were published in the Bulletin des Annonces Légales Obligatoires on March 18, 2026.
Electronic voting for the meeting will be available from March 18 to April 2, 2026, via the VOTACCESS platform. Details for accessing the platform are provided in the meeting notice and on Amoéba's website.
Amoéba specializes in natural microbiological solutions using patented amoebae and aims to expand in plant protection and cosmetics markets. The company holds regulatory approvals in the United States and is pending approvals in Europe for these applications.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AMOEBA news